You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國醫藥(600056.SH):擬收購金穗科技100%股權

格隆匯5月12日丨中國醫藥(600056.SH)公佈,爲進一步提升中國醫藥營銷能力和供應鏈管理能力,拓寬醫藥、醫療器械、大健康產品渠道發展新路徑,創新醫藥營銷模式,打造公司電商運營平臺,中國醫藥擬與新興集團簽署《關於北京金穗科技開發有限責任公司的100%股權轉讓協議》,以現金30,207萬元收購新興集團持有的金穗科技100%的股權。完成收購後,金穗科技將成爲中國醫藥全資子公司。

金穗科技成立於1993年5月,原隸屬於解放軍總後勤部北京企業管理局。1998年底,金穗科技與軍隊脫鉤重組,併入新興集團,現爲新興集團全資子公司。2011年底,金穗科技根據國家“互聯網+”發展政策導向,依據市場需要,以飛利浦業務爲依託,進入電商服務賽道。金穗科技主營業務爲電商運營服務,經過多年來與上遊品牌方與下遊平臺渠道資源的深度整合,與合作夥伴構建了較爲穩固的合作共贏體系,形成了自身一定的競爭優勢。其運營產品涵蓋個人健康消費產品、大健康等多個品類,已與飛利浦、歐姆龍等國內外知名品牌建立合作。目前的核心業務爲飛利浦個人健康消費等產品的品牌授權經銷。運營渠道包括京東、阿里、抖音、得物、小紅書、快手、唯品會等電商平臺及線下渠道。金穗科技業務模式主要爲授權經銷商模式和電商代運營模式兩種,團隊擁有超十年的電商平臺運營服務經驗,可爲品牌客戶提供包含供應鏈管理、電商精細化管理及全渠道運營、整合營銷等在內的一站式電商服務解決方案,並具備醫療器械、食品銷售及進出口貿易等經營資質。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account